IP Group news – IP Group plc

Search in site

2022 data tab

Date	Title
15 May 2018	IP Group plc IP Group and Johns Hopkins collaboration funds cancer therapeutic start-up
04 May 2018	IP Group plc Board changes
12 Apr 2018	IP Group plc Portfolio company Enterprise Therapeutics raises £29m funding
29 Mar 2018	IP Group plc Annual Results
20 Mar 2018	IP Group plc Portfolio company Oxford Nanopore Technologies announces £100m fundraising from global investors
08 Feb 2018	IP Group plc Parkwalk wins ‘Best EIS Fund Manager’ category at the EISA awards
18 Dec 2017	IP Group plc Portfolio company Autifony Therapeutics signs €627.5m collaboration agreement with Boehringer Ingelheim
15 Dec 2017	IP Group plc Portfolio company Diurnal receives positive CHMP opinion for Alkindi® (Infacort®) for the treatment of paediatric adrenal insufficiency in Europe
14 Dec 2017	IP Group plc Retirement of Non-executive Director
08 Dec 2017	IP Group plc Portfolio company Mirriad announces £26.2m fundraising and proposed admission to AIM

Loadmore